Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2026-03-03 @ 12:38 AM
Study NCT ID:
NCT06324357
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2024-03-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1479-0012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None